Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CELF2 antisense RNA 2 (CELF2-AS2) is a human long non-coding RNA gene (GenBank: 439950, HGNC: 44703) that produces a 2,277 nucleotide lncRNA transcript. It is antisense to the CELF2 gene but has no well-defined functional annotation or experimentally validated biological role as of September 2025. CELF2-AS2 is annotated in genomic resources and lncRNA databases; there is limited or no information available about its expression profile, mechanism, protein interactions, or disease contributions. Its naming as "antisense RNA" indicates its genomic position is opposite to the coding strand of CELF2, but there is no current evidence that it functions as a regulatory RNA or has direct physiological or pathological significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CELF2 antisense RNA 2 (CELF2-AS2).